Abstract
Angiopoietin-1 (Ang1) is an essential molecule for blood vessel formation. In an effort to produce large quantities of Ang1, recombinant Chinese hamster ovary (rCHO) cells expressing a high level of recombinant human Ang1 protein (rhAng1) with an amino terminal FLAG-tag were constructed by transfecting the expression vector into dihydrofolate reductase-deficient CHO cells and subsequent gene amplification in a medium containing step-wise increments of methotrexate, such as 0.02, 0.08, and 0.32 μM. The rhAng1 secreted from rCHO cells was purified at a purification yield of 18.4% from the cultured medium using an anti-FLAG M2 agarose affinity gel. SDS-PAGE and Western blot analyses showed that rCHO cells secret rhAng1 as heterogeneous multimers. Moreover, rhAng1 expressed in rCHO cells is biologically active in vitro as demonstrated by its ability to bind to the Tie2 receptor and to phosphorylate Tie2. Therefore, the rhAng1 produced from CHO cells could be useful for clarifying the biological effects of exogenous rhAng1 in the future.
References
Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254; 1976.
Brindle, N. P. J.; Saharinen, P.; Alitalo, K. Signaling and functions of Angiopoietin-1 in vascular protection. Circ. Res. 98:1014–1023; 2006.
Cho, C. H.; Kammerer, R. A.; Lee, H. J.; Steinmetz, M. O.; Ryu, Y. S.; Lee, S. H.; Yasunaga, K.; Kim, K. T.; Kim, I.; Choi, H. H.; Kim, W.; Kim, S. H.; Park, S. K.; Lee, G. M.; Koh, G. Y. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl. Acad. Sci. USA 101:5547–5552; 2004.
Davis, S.; Aldrich, T. H.; Jones, P. F.; Acheson, A.; Compton, D. L.; Jain, V.; Ryan, T. E.; Bruno, J.; Radziejewski, C.; Maisonpierre, P. C.; Yancopoulos, G. D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161–1169; 1996.
Davis, S.; Papadopoulos, N.; Aldrich, T. H.; Maisonpierre, P. C.; Huang, T.; Kovac, L.; Xu, A.; Leidich, R.; Radziejewska, E.; Rafique, A.; Goldberg, J.; Jain, V.; Bailey, K.; Karow, M.; Fandl, J.; Samuelsson, S. J.; Ioffe, E.; Rudge, J. S.; Daly, T. J.; Radziejewski, C.; Yancopoulos, G. D. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat. Struct. Biol. 10:38–44; 2003.
Fiedler, U.; Krissl, T.; Koidl, S.; Weiss, C.; Koblizek, T.; Deutsch, U.; Martiny-Baron, G.; Marme, D.; Augustin, H. G. Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J. Biol. Chem. 278:1721–1727; 2003.
Ge, H.; Yang, G.; Yu, X.; Pourbahrami, T.; Li, C. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J. Lipid Res. 45:2071–2079; 2004.
Goochee, C. F.; Gramer, M. J.; Andersen, D. C.; Bahr, J. B.; Rasmussen, J. R. The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties. Biotechnology 9:1347–1355; 1991.
Hori, S.; Ohtsuki, S.; Hosoya, K.; Nakashima, E.; Terasaki, T. A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J. Neurochem. 89:503–513; 2004.
Hwang, S. J.; Choi, H. H.; Kim, K. T.; Hong, H. J.; Koh, G. Y.; Lee, G. M. Expression and purification of recombinant human angiopoietin-2 produced in Chinese hamster ovary cells. Protein Express. Purif. 39:175–183; 2005.
Imai, N.; Kawamura, A.; Higuchi, M.; Oh-eda, M.; Orita, T.; Kawaguchi, T.; Ochi, N. Physicochemical and biological comparison of recombinant human erythropoietin with human urinary erythropoietin. J. Biochem. 107:352–359; 1990.
James, D. C.; Freedman, R. B.; Hoare, M.; Ogonah, O. W.; Rooney, B. C.; Larionov, O. A.; Dobrovolsky, V. N.; Lagutin, O. V.; Jenkins, N. N-glycosylation of recombinant human interferon-gamma produced in different animal expression systems. Biotechnology 13:592–596; 1995.
Joussen, A. M.; Poulaki, V.; Tsujikawa, A.; Qin, W.; Qaum, T.; Xu, Q.; Moromizato, Y.; Bursell, S. E.; Wiegand, S. J.; Rudge, J.; Ioffe, E.; Yancopoulos, G. D.; Adamis, A. P. Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol. 160:1683–1693; 2002.
Kim, S. J.; Kim, N. S.; Ryu, C. J.; Hong, H. J.; Lee, G. M. Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. Biotechnol. Bioeng. 58:73–84; 1998.
Kim, I.; Kim, H. G.; So, J. N.; Kim, J. H.; Kwak, H. J.; Koh, G. Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ. Res. 86:24–29; 2000.
Kim, I.; Moon, S. O.; Park, S. K.; Chae, S. W.; Koh, G. Y. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ. Res. 89:477–479; 2001a.
Kim, T. K.; Chung, J. Y.; Sung, Y. H.; Lee, G. M. Relationship between cell size and specific thrombopoietin productivity in Chinese hamster ovary cells during dihydrofolate reductase-mediated gene amplification. Biotechnol. Bioprocess Eng. 6:332–336; 2001b.
Kim, I.; Moon, S. O.; Han, C. Y.; Park, Y. K.; Moon, S. K.; Kim, J. J.; Koh, G. Y. The angiopoietin-tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosis. Cardiovasc. Res. 49:872–881; 2001c.
Kim, K. T.; Choi, H. H.; Steinmetz, M. O.; Maco, B.; Kammerer, R. A.; Ahn, S. Y.; Kim, H. Z.; Lee, G. M.; Koh, G. Y. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J. Biol. Chem. 280:20126–20131; 2005.
Maisonpierre, P. C.; Suri, C.; Jones, P. F.; Bartunkova, S.; Wiegand, S. J.; Radziejewski, C.; Compton, D.; McClain, J.; Aldrich, T. H.; Papadopoulos, N.; Daly, T. J.; Davis, S.; Sato, T. N.; Yancopoulos, G. D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60; 1997.
McDonald, D. M. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am. J. Respir. Crit. Care Med. 164:S39–S45; 2001.
Nykanen, A. I.; Krebs, R.; Saaristo, A.; Turumen, P.; Alitalo, K.; Yla-Herttuala, S.; Koskinen, P. K.; Lemstrom, K. B. Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 107:1308–1314; 2003.
Parekh, R. B. Mammalian cell gene expression: protein glycosylation. Curr. Opin. Biotechnol. 2:730–734; 1991.
Patel, J. I.; Hykin, P. G.; Gregor, Z. J. Angiopoietin concentrations in diabetic retinopathy. Br. J. Ophthalmol. 89:480–483; 2005.
Procopio, W. N.; Pelavin, P. I.; Lee, W. M.; Yeilding, N. M. Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J. Biol. Chem. 274:30196–30201; 1999.
Reff, M. E. High-level production of recombinant immunoglobulins in mammalian cells. Curr. Opin. Biotechnol. 4:573–576; 1993.
Sato, T. N.; Qin, Y.; Kozak, C. A.; Audus, K. L. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. U S A 90:9355–9358; 1993.
Suri, C.; Jones, P. F.; Patan, S.; Bartunkova, S.; Maisonpierre, P. C.; Davis, S.; Sato, T. N.; Yancopoulos, G. D. Requisite role of angiopoietin-1, a ligand for the TIE2 Receptor, during embryonic angiogenesis. Cell 87:1171–1180; 1996.
Suri, C.; McClain, J.; Thurston, G.; McDonald, D. H.; Zhou, H.; Oldmixon, E. H.; Sato, T. N.; Yancopoulos, G. D. Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468–471; 1998.
Thurston, G.; Rudge, J. S.; Ioffe, E.; Zhou, H.; Ross, L.; Croll, S. D.; Glazer, N.; Holash, J.; McDonald, D. M.; Yancopoulos, G. D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6:460–463; 2000.
Thurston, G.; Suri, C.; Smith, K.; McClain, J.; Sato, T. N.; Yancopoulos, G. D.; McDonald, D. M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511–2514; 1999.
Witzenbichler, B.; Westermann, D.; Knueppel, S.; Schultheiss, H. P.; Tschope, C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 111:97–105; 2005.
Wurm, F. M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 22:1393–1398; 2004.
Acknowledgments
This research was supported in part by grants from the Ministry of Commerce, Industry, and Energy and Daejon City (Bio/RIS program) and the Ministry of Education (Brain Korea 21 Program).
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Hwang, SJ., Kim, HZ., Koh, G.Y. et al. Expression and purification of recombinant human Angiopoietin-1 produced in Chinese hamster ovary cells. In Vitro Cell.Dev.Biol.-Animal 43, 162–167 (2007). https://doi.org/10.1007/s11626-007-9037-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-007-9037-1